These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 12521278)
1. Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia. Al-Mazrou Y; Tumsah S; Khalil M; Al-Jeffri M; Afzal MA; al-Ghamdy Y; Mishkhas A; Essa M J Trop Pediatr; 2002 Dec; 48(6):354-8. PubMed ID: 12521278 [TBL] [Abstract][Full Text] [Related]
2. Effect of gender on reporting of MMR adverse events in Saudi Arabia. Khalil MK; Al-Mazrou YY; Al-Ghamdi YS; Tumsah S; Al-Jeffri M; Meshkhas A East Mediterr Health J; 2003; 9(1-2):152-8. PubMed ID: 15562745 [TBL] [Abstract][Full Text] [Related]
3. The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997. da Silveira CM; Kmetzsch CI; Mohrdieck R; Sperb AF; Prevots DR Int J Epidemiol; 2002 Oct; 31(5):978-82. PubMed ID: 12435771 [TBL] [Abstract][Full Text] [Related]
4. Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom. Miller E; Andrews N; Stowe J; Grant A; Waight P; Taylor B Am J Epidemiol; 2007 Mar; 165(6):704-9. PubMed ID: 17204517 [TBL] [Abstract][Full Text] [Related]
6. Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Paraná, Brazil, 1998. Arruda WO; Kondageski C Rev Inst Med Trop Sao Paulo; 2001; 43(5):301-2. PubMed ID: 11696855 [TBL] [Abstract][Full Text] [Related]
7. Surveillance of measles-mumps-rubella vaccine-associated aseptic meningitis in Germany. Schlipköter U; Mühlberger N; von Kries R; Weil J Infection; 2002 Dec; 30(6):351-5. PubMed ID: 12478324 [TBL] [Abstract][Full Text] [Related]
8. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Marin M; Broder KR; Temte JL; Snider DE; Seward JF; MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530 [TBL] [Abstract][Full Text] [Related]
9. Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. da Cunha SS; Rodrigues LC; Barreto ML; Dourado I Vaccine; 2002 Jan; 20(7-8):1106-12. PubMed ID: 11803071 [TBL] [Abstract][Full Text] [Related]
10. No demonstrable association between the Leningrad-Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt. Sharma HJ; Oun SA; Bakr SS; Kapre SV; Jadhav SS; Dhere RM; Bhardwaj S Clin Microbiol Infect; 2010 Apr; 16(4):347-52. PubMed ID: 20222892 [TBL] [Abstract][Full Text] [Related]
11. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection. Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672 [TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age. Yadav S; Thukral R; Chakarvarti A Indian J Med Res; 2003 Nov; 118():183-6. PubMed ID: 14723482 [TBL] [Abstract][Full Text] [Related]
14. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia. Jaber SM Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years. Vesikari T; Baer M; Willems P Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879 [TBL] [Abstract][Full Text] [Related]
16. Neurologic disorders after measles-mumps-rubella vaccination. Mäkelä A; Nuorti JP; Peltola H Pediatrics; 2002 Nov; 110(5):957-63. PubMed ID: 12415036 [TBL] [Abstract][Full Text] [Related]
17. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS; MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231 [TBL] [Abstract][Full Text] [Related]
18. Statistical analysis of MMR vaccine adverse events on aseptic meningitis using the case cross-over design. Park T; Ki M; Yi SG Stat Med; 2004 Jun; 23(12):1871-83. PubMed ID: 15195321 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial. Sood A; Mitra M; Joshi HA; Nayak US; Siddaiah P; Babu TR; Mahapatro S; Sanmukhani J; Gupta G; Mittal R; Glueck R Hum Vaccin Immunother; 2017 Jul; 13(7):1523-1530. PubMed ID: 28362563 [TBL] [Abstract][Full Text] [Related]
20. Serosurvey of measles, mumps and rubella antibodies in Saudi children. Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]